norcantharidin has been researched along with Lupus Erythematosus, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, LJ; Feng, YX; He, ZX; Huang, L; Wang, Q; Wen, CP; Zhang, Y | 1 |
1 other study(ies) available for norcantharidin and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Female; Interleukin-17; Lupus Erythematosus, Systemic; Mice; Mice, Inbred MRL lpr; Th17 Cells | 2022 |